Curasight
BioStock: Curasight gets green light from EMA in phase II prostate cancer trial
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
Datum | 2024-04-22, kl 08:45 |
Källa | Cision |

Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.